Genetic profile predicts which bladder cancer patients will benefit from early chemotherapy

Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings. These results suggest that doctors may one day sequence patients' tumors for the presence of these three mutations, to determine who will likely benefit most from chemotherapy before surgery, said one investigator.

Read the whole article on Science Daily

More from Science Daily